日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Potential of Streptomyces rochei 8ER183 for poly(lactic acid)-degrading enzyme production, biodegradative capability, and its whole-genome sequence characterization

链霉菌 8ER183 产生聚乳酸降解酶的潜力、生物降解能力及其全基因组序列表征

期刊:
影响因子:
doi:10.1007/s13205-025-04219-3
Sujarit, Kanaporn; Pannim, Butsakorn; Kuakkhunthod, Nattawan; Uywannang, Udomlak; Sakdapetsiri, Chatsuda; Panyachanakul, Titiporn; Krajangsang, Sukhumaporn; Phanngoen, Supattra; Kitpreechavanich, Vichien; Lomthong, Thanasak
发表日期：2025
文献求助 收藏

Profiling of the bacterial community and the degradative capability of newly isolated poly(lactic acid) (PLA)- and poly(butylene succinate) (PBS)-degrading bacteria from coastal samples

对沿海样品中新分离的聚乳酸（PLA）和聚丁二酸丁二醇酯（PBS）降解菌的细菌群落组成和降解能力进行分析

期刊:
影响因子:
doi:10.1007/s13205-025-04521-0
Phonlamai, Ausawadee; Khetkorn, Wanthanee; Thongpool, Voranuch; Panyachanakul, Titiporn; Suriyachadkun, Chanwit; Kitpreechavanich, Vichien; Sakdapetsiri, Chatsuda; Lomthong, Thanasak
微生物学
发表日期：2025
文献求助 收藏

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study

KEYNOTE-042 研究中，帕博利珠单抗与化疗作为一线治疗方案在非小细胞肺癌且程序性死亡配体-1 肿瘤比例评分≥1%的患者中的五年疗效

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.02885
de Castro, Gilberto Jr; Kudaba, Iveta; Wu, Yi-Long; Lopes, Gilberto; Kowalski, Dariusz M; Turna, Hande Z; Caglevic, Christian; Zhang, Li; Karaszewska, Boguslawa; Laktionov, Konstantin K; Srimuninnimit, Vichien; Bondarenko, Igor; Kubota, Kaoru; Mukherjee, Rinee; Lin, Jianxin; Souza, Fabricio; Mok, Tony S K; Cho, Byoung Chul
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Cost-Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand

泰国政策实施后，口服化疗治疗III期结直肠癌的成本效益和预算影响分析：真实世界证据

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15204930
Phisalprapa, Pochamana; Kositamongkol, Chayanis; Korphaisarn, Krittiya; Akewanlop, Charuwan; Srimuninnimit, Vichien; Supakankunti, Siripen; Apiraksattayakul, Natnasak; Chaiyakunapruk, Nathorn
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Conversion of golden oyster mushroom, Pleurotus citrinopileatus to sugar syrup using enzymatic hydrolysis as a substrate for novel bacterial cellulose (Nata) fermentation

利用酶水解法将金黄色平菇（Pleurotus citrinopileatus）转化为糖浆，并以新型细菌纤维素（Nata）发酵为底物

期刊:
影响因子:
doi:10.1007/s13205-022-03274-4
Chorum, Manida; Suphan, Sutthawan; Khetkorn, Wanthanee; Sujarit, Kanaporn; Naloka, Kallayanee; Saithong, Pramuan; Kitpreechavanich, Vichien; Lomthong, Thanasak
微生物学
发表日期：2022
文献求助 收藏

Application of raw starch degrading enzyme from Laceyella sacchari LP175 for development of bacterial cellulose fermentation using colored rice as substrate

利用来自糖乳杆菌LP175的生淀粉降解酶，以有色大米为底物开发细菌纤维素发酵工艺

期刊:
影响因子:
doi:10.1007/s13205-021-02673-3
Noree, Sirilak; Tongdang, Chantanan; Sujarit, Kanaporn; Chamdit, Songphon; Thongpool, Voranuch; Trakarnpaiboon, Srisakul; Khunnamwong, Pannida; Kitpreechavanich, Vichien; Lomthong, Thanasak
微生物学
发表日期：2021
文献求助 收藏

Production and development of vinegar fermentation from broken Riceberry rice using raw starch-degrading enzyme hydrolysis

利用生淀粉降解酶水解法，从碎米中发酵生产和开发醋

期刊:
影响因子:
doi:10.1007/s13205-020-02488-8
Sangngern, Nujarin; Puangnark, Thidarat; Nguansangiam, Watsachon; Saithong, Pramuan; Kitpreechavanich, Vichien; Lomthong, Thanasak
发表日期：2020
文献求助 收藏

Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

BP-C1治疗转移性乳腺癌的疗效和耐受性：一项II期、随机、双盲、安慰剂对照的泰国多中心研究

期刊:Breast Cancer-Targets and Therapy
影响因子:3.4
doi:10.2147/BCTT.S174298
Butthongkomvong, Kritiya; Raunroadroong, Nilubol; Sorrarichingchai, Sirikul; Sangsaikae, Isaraporn; Srimuninnimit, Vichien; Harling, Henrik; Larsen, Stig
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial

依维莫司联合内分泌治疗雌激素受体阳性、人表皮生长因子受体2阴性的绝经后晚期乳腺癌女性患者：一项临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.0060
Royce, Melanie; Bachelot, Thomas; Villanueva, Cristian; Özgüroglu, Mustafa; Azevedo, Sergio J; Cruz, Felipe Melo; Debled, Marc; Hegg, Roberto; Toyama, Tatsuya; Falkson, Carla; Jeong, Joon; Srimuninnimit, Vichien; Gradishar, William J; Arce, Christina; Ridolfi, Antonia; Lin, Chinjune; Cardoso, Fatima
肿瘤
肿瘤免疫
信号转导
乳腺癌
Human
免疫/内分泌
发表日期：2018
文献求助 收藏

Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer

泰国早期或转移性三阴性乳腺癌患者的真实临床模式、治疗和生存情况

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0209040
Srimuninnimit, Vichien; Pornpraserthsuk, Piti; Chaiwerawattana, Arkom; Kongdan, Youwanush; Namkanisorn, Teerayuth; Somwangprasert, Areewan; Jatuparisuthi, Chulaporn; Puttawibul, Puttisak; Vongsaisuwan, Mawin; Thongthieang, Luangyot; Bandidwattanawong, Chanyoot; Tantimongkolsuk, Chaturong
肿瘤免疫
肿瘤
乳腺癌
发表日期：2018
文献求助 收藏